We’re an
AI-native pharma
company.

We mine the corpus of biomedical knowledge to find treatments for rare diseases.

The corpus of biomedical knowledge is too vast for humans to search through.

Our AI agents make this expansive search for treatments feasible.

An illustrative hexagonal pathway connects Disease, Physiology, Cell state, Pathway, Target, and Drug within one biomedical knowledge graph. Disease and Drug sit at the upper left and upper right. A dotted connection returns from Drug to Disease to indicate a treatment hypothesis for further evaluation. The view pulls back from these same nodes to reveal more of the network, where agents highlight additional intersecting disease-to-drug pathways.

We're pushing the economic frontier of medicine until market size ceases to determine which forms of suffering deserve a treatment.